Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Bijna kwart miljoen mensen met recept van neuroloog
jan 2019 | Bewegingsstoornissen, Epilepsie, Neuro-vasculair, Overig